| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2007 | EP1747227A2 Combinatorial selection of phosphorothioate aptamers for tgf-beta |
| 01/31/2007 | EP1747226A1 Pharmaceuticals for enhanced deliver to disease targets |
| 01/31/2007 | EP1747024A2 Dna virus microrna and methods for inhibiting same |
| 01/31/2007 | EP1392838B1 Pseudotyping of hiv vectors with mokola virus envelopes |
| 01/31/2007 | EP1240519B1 Compositions and methods for detecting treponema pallidum |
| 01/31/2007 | EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection |
| 01/31/2007 | EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/31/2007 | CN1906307A Methods for purifying pertussis toxin and peptides useful therefor |
| 01/31/2007 | CN1906301A HIV-1 Indian subtype C vaccine constructs for use in humans |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906298A Ice recrystallisation inhibition protein or antifreeze proteins from deschampsia, lolium and festuca species of grass |
| 01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
| 01/31/2007 | CN1906296A Methods for the production of apolipoproteins in transgenic plants |
| 01/31/2007 | CN1906291A Process for the preparation of l-amino acids with amplification of the zwf gene |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906210A Surface-located campylobacter jejuni polypeptides |
| 01/31/2007 | CN1906209A Stabilized alpha helical peptides and uses thereof |
| 01/31/2007 | CN1906205A Reduction of dermal scarring |
| 01/31/2007 | CN1905892A Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/31/2007 | CN1905806A Gel-shell beads with adsorbed or bound biomolecules |
| 01/31/2007 | CN1904150A Human glucagon peptide/derivative and its solid phase chemical synthesis |
| 01/31/2007 | CN1903918A Method of extracting collagen and method of using collagen to prepare collagen protein |
| 01/31/2007 | CN1903877A Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/31/2007 | CN1903876A Polypeptide, nucleic acid molecule coding it and use |
| 01/31/2007 | CN1903875A Antitumour integrator alpha V beta 3 antigen and its coding gene and application |
| 01/31/2007 | CN1903874A Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody |
| 01/31/2007 | CN1297666C Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/31/2007 | CN1297661C A rice blast resistance gene, its encoded protein and use thereof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297316C Mutant forms of cholera holotoxin as adjuvant |
| 01/30/2007 | US7169972 Methods and compositions to modulate ethylene sensitivity |
| 01/30/2007 | US7169971 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/30/2007 | US7169964 Genetic control of organ abscission |
| 01/30/2007 | US7169963 Transgenic swine which produce growth factors which facilitate piglet development and decrease mortality; veterinary medicine |
| 01/30/2007 | US7169911 Abortive defense protein; milk fermentation; cultures |
| 01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
| 01/30/2007 | US7169906 Nucleotide sequences coding polypeptide for use in the treatment of skin and nervous system disorders |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169902 Collagen-binding proteins from Streptococcus pyogenes |
| 01/30/2007 | US7169900 Polyoxyalkylene glycols with amino acid end groups bonded by the amine to hemoglobin by an amide linkage ( Glu-43, Glu-22 and/or Asp-47); blood substitute with increased circulation half-life; low vasoactivity; traps nitric oxide in septic shocks; modulate tissue oxygenation during radiation therapy |
| 01/30/2007 | US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 01/30/2007 | US7169897 Adipocyte complement related protein ZACRP3X2 |
| 01/30/2007 | US7169896 Producing partially modified and partially hydrolysed fiberous protein; isolate feather, solubilize, incubate with reducing agent, recover protein; isolating fiberous protein from waste feathers for use in textile processing and supplementing cosmetics |
| 01/30/2007 | US7169895 Human neuronal nicotinic acetylcholine receptor α6 and β3 |
| 01/30/2007 | US7169894 Methods and compositions for reverse translation |
| 01/30/2007 | US7169893 Human HAC3 |
| 01/30/2007 | US7169891 Human pellino polypeptides |
| 01/30/2007 | US7169889 Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
| 01/30/2007 | US7169818 Lysophosphatidic acid receptor agonists and antagonists |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169612 Use of EDG2 receptor in an animal model of heart failure |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169589 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction |
| 01/30/2007 | US7169587 LysE proteins; fermentation; animal feeds; dihydrodipicolinate synthases; amino acid biosynthesis |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169582 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/30/2007 | US7169581 IL-18 receptors |
| 01/30/2007 | US7169573 Monitoring effective thrombin levels in patients undergoing anticoagulant therapy; measuring circulating levels of soluble endothelial protein C receptor (sEPCR) |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169569 Screening methods using novel Bt toxin receptors from lepidopteran insects |
| 01/30/2007 | US7169567 Screening for an agonist or an antagonist of PTH receptor activity: |
| 01/30/2007 | US7169566 Metalloproteinases |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169399 Administering intranasally an antigen which is a non-toxic double mutant form of pertussis toxin inducing an immune response |
| 01/30/2007 | US7169397 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 01/30/2007 | US7169396 nucleotide sequences of the genomes of eleven molecular clones for non-subtype B isolates of human immunodeficiency virus type 1; vaccine |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/30/2007 | US7169393 Antigenic peptide fragments of VapA protein, and uses thereof |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169388 unexpected discovery that the inhibition or antagonism of TNF decreases the expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF). VEGF has been implicated in the angiogenesis in cancer, vascular diseases and rheumatoid arthritis |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169386 Chimeric immunoglobulin; for the diagnosis and treatment of bacterail infection, cancer and septic shock |
| 01/30/2007 | US7169384 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 01/30/2007 | US7169383 Attaching substances to micro-organisms |
| 01/30/2007 | US7168847 Device for mixing and/or injecting cements |
| 01/30/2007 | CA2484115C Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 01/30/2007 | CA2351553C Transgenic animals |
| 01/30/2007 | CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor |
| 01/30/2007 | CA2247328C Neuropeptides originating in scorpion |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2166973C Immortalized human fetal osteoblastic cells |
| 01/30/2007 | CA2138991C Treatment for sensitive teeth |
| 01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
| 01/30/2007 | CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination |
| 01/25/2007 | WO2007012004A2 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 01/25/2007 | WO2007011975A2 Methods to express recombinant proteins from lentiviral vectors |
| 01/25/2007 | WO2007011859A2 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | WO2007011845A2 Use of a bacillus meti gene to improve methionine production in microorganisms |
| 01/25/2007 | WO2007011756A2 Insect chemosensory receptors and methods of use thereof |
| 01/25/2007 | WO2007011681A2 Yield increase in plants overexpressing the hsrp genes |
| 01/25/2007 | WO2007011670A2 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | WO2007011415A2 Rhob variants and methods comprising the use thereof |
| 01/25/2007 | WO2007011372A2 Therapeutic and prognostic factor yy1 in human cancer |
| 01/25/2007 | WO2007011265A1 Method for blocking noggin2 target specific activities |
| 01/25/2007 | WO2007011210A2 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/25/2007 | WO2007011202A1 Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene |
| 01/25/2007 | WO2007011166A1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 01/25/2007 | WO2007011044A1 Pharmaceutical composition comprising disulfide-linked hla-g dimer and process for production of disulfide-linked hla-g dimer |